The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN Competitive Renewal Opportunity, 2024IMPACT-PD: Implications of Polyamine and Glucosylceramide Transport in Parkinson’s Disease
Study Rationale: Mutations in the genes ATP13A2, GBA1 and ATP10B trigger Parkinson’s disease (PD) and cause dysfunction of lysosomes, the recycling compartments of the cell. These genes regulate the...
-
Measuring Alpha-Synuclein in Extracellular Vesicles, 2024Measuring Alpha-synuclein in Extracellular Vesicles: A Biomarker for the Diagnosis and Staging of Neuronal α-Synuclein Diseases
Study Rationale: Parkinson's disease (PD) and dementia with Lewy bodies involve accumulation of alpha-synuclein in neurons. A recently developed test for alpha-synuclein aggregates in cerebrospinal...
-
ASAP CRN Competitive Renewal Opportunity, 2024Examining the Mechanisms of Mitochondrial Damage Control by PINK1 and Parkin
Study Rationale: Mutations in PINK1 and Parkin genes underlie some forms of Parkinson’s disease (PD). The protein products of these genes are responsible for the maintenance and degradation of...
-
ASAP CRN Competitive Renewal Opportunity, 2024Studying Basal Ganglia Networks in Parkinson's Disease
Study Rationale: People with Parkinson's disease (PD) have long been known to display remarkable motor abilities under special circumstances, such as situations that involve strong emotions or stress...
-
ASAP CRN Competitive Renewal Opportunity, 2024Determining the Role of Proteins Associated with Parkinson’s Disease in T cell-Mediated Destruction of Dopamine Neurons
Study Rationale: Before Parkinson's disease (PD) manifests its characteristic symptoms, the pathological process has been underway for years. Although the initial trigger remains uncertain, we have...
-
ASAP CRN Competitive Renewal Opportunity, 2024Circuit Mechanisms for Dopamine Neuron Vulnerability and Resilience in Parkinson’s Disease
Study Rationale: Dopamine neurons are particularly vulnerable to death in Parkinson’s disease (PD), and their loss is one of the main causes of movement problems in people with PD. Dopamine neurons...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.